Resistance to change still greatest barrier to AI drug discovery

Resistance to change has emerged as the biggest barrier (51%) to data innovation in the pharmaceutical industry, while lack of…

Drug development

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar]

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes | Certara …

Drug development

Xaira taps scGPT pioneer Bo Wang to lead biomedical AI

Bo Wang, Ph.D., is a Xairanaut. That is, he’s the latest high-profile scientific leader to join the unicorn Xaira Therapeutics,…

Drug development

Early studies identify a new treatment for E coli infections

Scientists have taken an important step toward the development of a potential new treatment for treating Shiga toxin-producing E coli…

Drug development

Unlocking the Power of Oligonucleotide Therapeutics: A Model-Informed Approach with Certara & Ionis

Clinical Pharmacology Leader, Ionis Pharmaceuticals Pratap Singh, Ph.D., is currently an Executive Director and Franchise head within the Clinical pharmacology…

Drug development

2024’s blockbusters: Top 25 drugs by sales

In 2024, Merck’s Keytruda continued to dominate with $29.5 billion in sales, growing 18% over 2023’s $25 billion in sales.…

Drug development